KLK3 and benign prostatic hyperplasia: However, in this expanded cohort, the expression of PSA showed no significant difference between aggressive prostate cancer cases and BPH/ indolent prostate cancer cases (Figure 4C), which indicated a limitation of PSA on distinguishing these two cases.